TCM
BIIB icon

Traynor Capital Management’s Biogen BIIB Stock Holding History

Traynor Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,730
Closed -$6.43M – 225
2021
Q3 		$6.43M Sell
22,730
-2,353
-9% -$771K 0.88% 25
2021
Q2 		$8.75M Sell
25,083
-2,221
-8% -$673K 1.22% 18
2021
Q1 		$7.64M Buy
27,304
+899
+3% +$242K 1.26% 20
2020
Q4 		$6.46M Buy
26,405
+3,320
+14% +$856K 1.15% 22
2020
Q3 		$6.12M Sell
23,085
-446
-2% -$124K 1.4% 12
2020
Q2 		$6.29M Buy
23,531
+4,073
+21% +$1.22M 1.52% 10
2020
Q1 		$6.16M Buy
19,458
+2,940
+18% +$892K 2.19% 10
2019
Q4 		$4.9M Sell
16,518
-212
-1% -$58.8K 1.31% 18
2019
Q3 		$3.9M Sell
16,730
-305
-2% -$71K 1.22% 19
2019
Q2 		$4.01M Buy
17,035
+2,972
+21% +$686K 1.3% 16
2019
Q1 		$3.32M Buy
14,063
+4,094
+41% +$1.29M 1.11% 22
2018
Q4 		$3M Buy
9,969
+568
+6% +$181K 1.25% 18
2018
Q3 		$3.32M Buy
9,401
+337
+4% +$116K 1.08% 19
2018
Q2 		$2.68M Buy
9,064
+440
+5% +$124K 0.98% 21
2018
Q1 		$2.36M Buy
8,624
+1,760
+26% +$546K 0.96% 23
2017
Q4 		$2.19M Buy
6,864
+1,481
+28% +$475K 0.93% 26
2017
Q3 		$1.67M Buy
5,383
+338
+7% +$100K 0.79% 28
2017
Q2 		$1.44M Buy
5,045
+1,329
+36% +$351K 0.71% 32
2017
Q1 		$1.01M Buy
3,716
+1,160
+45% +$328K 0.56% 37
2016
Q4 		$705K Buy
2,556
+459
+22% +$136K 0.47% 45
2016
Q3 		$618K Buy
2,097
+247
+13% +$73.2K 0.44% 51
2016
Q2 		$447K Sell
1,850
-1,070
-37% -$282K 0.35% 63
2016
Q1 		$760K Sell
2,920
-267
-8% -$70.5K 0.61% 37
2015
Q4 		$976K Sell
3,187
-104
-3% -$29.9K 0.7% 35
2015
Q3 		$960K Buy
3,291
+1,311
+66% +$433K 0.83% 26
2015
Q2 		$799K Buy
+1,980
New +$795K 0.67% 32

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Traynor Capital Management's BIIB Position: Q4 2021 in Review

Traynor Capital Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 22,730 shares — an estimated $6.43M sold.

Traynor Capital Management first reported a position in BIIB in Q2 2015 and held it in 26 quarters. The position peaked at $8.75M in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Traynor Capital Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Traynor Capital Management sold 22,730 Biogen shares in Q4 2021, an estimated $6.43M.
  • Traynor Capital Management first reported a position in Biogen in Q2 2015 and held it in 26 quarters.
  • Traynor Capital Management's Biogen position peaked at $8.75M in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Traynor Capital Management's 13F filing for Q4 2021, filed 1 Feb 2022.